Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 EUR | +2.39% | +3.21% | +14.22% |
Mar. 13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 | |
Feb. 29 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 274M 295M | Sales 2023 | 318M 342M | Capitalization | 177M 190M |
---|---|---|---|---|---|
Net income 2022 | 8M 8.59M | Net income 2023 | 9M 9.67M | EV / Sales 2022 | 0.82 x |
Net Debt 2022 | 54.76M 58.82M | Net Debt 2023 | 47.92M 51.47M | EV / Sales 2023 | 0.71 x |
P/E ratio 2022 |
21.9
x | P/E ratio 2023 |
18.8
x | Employees | 1,331 |
Yield 2022 |
1.83% | Yield 2023 |
-
| Free-Float | 19.99% |
Latest transcript on Laboratorio Reig Jofre, S.A.
1 day | +2.39% | ||
1 week | +3.21% | ||
Current month | +3.21% | ||
1 month | +1.58% | ||
3 months | +10.30% | ||
6 months | +3.63% | ||
Current year | +14.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 02-12-31 |
Chief Operating Officer | 52 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Director/Board Member | - | 14-12-30 | |
Director/Board Member | - | 14-12-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 2.57 | +2.39% | 5,673 |
24-05-06 | 2.51 | -1.18% | 4,233 |
24-05-03 | 2.54 | +1.60% | 4,064 |
24-05-02 | 2.5 | +0.40% | 2,987 |
24-04-30 | 2.49 | -0.80% | 3,647 |
Delayed Quote BME, May 07, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.22% | 218M | |
+33.43% | 700B | |
+26.43% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+14.32% | 236B | |
+5.79% | 202B | |
-9.49% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- RJF Stock